The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
From day one ASTP has been a tremendous help. Learning throughs seminars and workshops or meeting peers for discussions, there is always someone around to exchange ideas with.
Paul van Dun
KU Leuven, Belgium
Always simply inspiring! That is ASTP.
Filip Auinger
Palacký University Olomouc, Czech Republic
Three days of learning and networking in Dublin at ASTP annual conference. What a great event!!
Sandra Aresta
CIBIO - Centro de Investigação em Biodiversidade e Recursos Genéticos, Portugal
Exciting training, even after almost 10 hours I am curious about more experience and knowledge.
Petr Suchomel
Palacký University Olomouc, Czech Republic
This was the right decision giving me the broadest overview, confidence, tools, network and support that is fundamental to feel right in my daily decision process and to keep on learning.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
Join our newsletter and get the latest news